You are here

19 October 2018 to 22 October 2018
Munich, Germany

Novosanis is excited to join ESMO for the first time and showcase our Colli-Pee device for first-void urine sampling and our VAX-ID drug delivery platform. Come and talk to our CEO, Vanessa Vankerckhoven & CTO, Koen Beyers.

The ESMO 2018 Congress will provide a scientific and educational programme able to directly impact the daily clinical practice of oncologists. This year, the programme also features a dedicated nursing track through a collaboration with the European Oncology Nursing Society (EONS).